Cargando…

Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study

INTRODUCTION: A remarkable difference in care delivery pathways for Chronic Obstructive Pulmonary Disease (COPD) is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. The objective of this paper is to explain this difference. METHODS: Descriptive C...

Descripción completa

Detalles Bibliográficos
Autores principales: Utens, Cecile M.A, Maarse, J.A.M, van Schayck, Onno C.P, Maesen, Boudewijn L.P, Rutten, Maureen P.M.H, Smeenk, Frank W.J.M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Igitur, Utrecht Publishing & Archiving 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440249/
https://www.ncbi.nlm.nih.gov/pubmed/22977431
_version_ 1782243129413337088
author Utens, Cecile M.A
Maarse, J.A.M
van Schayck, Onno C.P
Maesen, Boudewijn L.P
Rutten, Maureen P.M.H
Smeenk, Frank W.J.M
author_facet Utens, Cecile M.A
Maarse, J.A.M
van Schayck, Onno C.P
Maesen, Boudewijn L.P
Rutten, Maureen P.M.H
Smeenk, Frank W.J.M
author_sort Utens, Cecile M.A
collection PubMed
description INTRODUCTION: A remarkable difference in care delivery pathways for Chronic Obstructive Pulmonary Disease (COPD) is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. The objective of this paper is to explain this difference. METHODS: Descriptive COPD statistics and care delivery pathways on all care levels within the institutional context, followed by a comparison of care delivery pathways and an explanation of the difference with regard to hospital-at-home. RESULTS: The Netherlands and England show broad similarities in their care delivery pathways for COPD patients. A major difference is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. Three possible explanations for this difference are presented: differences in the urgency for alternatives (higher urgency for alternative treatment models in England), the differences in funding (funding in England facilitated the development of hospital-at-home) and the differences in the substitution of tasks to nurses (substitution to nurses has taken place to a larger extent in England). DISCUSSION AND CONCLUSION: The difference between the Netherlands and England regarding hospital-at-home for COPD exacerbations can be explained in three ways. Hospital-at-home has proved to be a safe alternative for hospital care for selected patients, and should be considered as a treatment option for COPD exacerbations in the Netherlands.
format Online
Article
Text
id pubmed-3440249
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Igitur, Utrecht Publishing & Archiving
record_format MEDLINE/PubMed
spelling pubmed-34402492012-09-13 Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study Utens, Cecile M.A Maarse, J.A.M van Schayck, Onno C.P Maesen, Boudewijn L.P Rutten, Maureen P.M.H Smeenk, Frank W.J.M Int J Integr Care Policy Paper INTRODUCTION: A remarkable difference in care delivery pathways for Chronic Obstructive Pulmonary Disease (COPD) is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. The objective of this paper is to explain this difference. METHODS: Descriptive COPD statistics and care delivery pathways on all care levels within the institutional context, followed by a comparison of care delivery pathways and an explanation of the difference with regard to hospital-at-home. RESULTS: The Netherlands and England show broad similarities in their care delivery pathways for COPD patients. A major difference is the presence of hospital-at-home for COPD exacerbations in England and its absence in the Netherlands. Three possible explanations for this difference are presented: differences in the urgency for alternatives (higher urgency for alternative treatment models in England), the differences in funding (funding in England facilitated the development of hospital-at-home) and the differences in the substitution of tasks to nurses (substitution to nurses has taken place to a larger extent in England). DISCUSSION AND CONCLUSION: The difference between the Netherlands and England regarding hospital-at-home for COPD exacerbations can be explained in three ways. Hospital-at-home has proved to be a safe alternative for hospital care for selected patients, and should be considered as a treatment option for COPD exacerbations in the Netherlands. Igitur, Utrecht Publishing & Archiving 2012-05-18 /pmc/articles/PMC3440249/ /pubmed/22977431 Text en Copyright 2012, International Journal of Integrated Care (IJIC) http://creativecommons.org/licenses/by/3.0/ This work is licensed under a (http://creativecommons.org/licenses/by/3.0) Creative Commons Attribution 3.0 Unported License
spellingShingle Policy Paper
Utens, Cecile M.A
Maarse, J.A.M
van Schayck, Onno C.P
Maesen, Boudewijn L.P
Rutten, Maureen P.M.H
Smeenk, Frank W.J.M
Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study
title Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study
title_full Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study
title_fullStr Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study
title_full_unstemmed Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study
title_short Care delivery pathways for Chronic Obstructive Pulmonary Disease in England and the Netherlands: a comparative study
title_sort care delivery pathways for chronic obstructive pulmonary disease in england and the netherlands: a comparative study
topic Policy Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440249/
https://www.ncbi.nlm.nih.gov/pubmed/22977431
work_keys_str_mv AT utenscecilema caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy
AT maarsejam caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy
AT vanschayckonnocp caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy
AT maesenboudewijnlp caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy
AT ruttenmaureenpmh caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy
AT smeenkfrankwjm caredeliverypathwaysforchronicobstructivepulmonarydiseaseinenglandandthenetherlandsacomparativestudy